As a journalist, I have rewritten the article to create a unique piece that delves deeper into the world of anti-obesity medications like Ozempic, Wegovy, Mounjaro, and Zepbound. Our series of episodes will feature conversations with specialists in the field to provide an in-depth look at these medicines beyond what’s been reported in the headlines.
To begin our journey, we are joined by Dr. Carolyn Jasik, Chief Medical Officer at Omada Health. She provides us with a comprehensive overview of the science behind satiety, insights from obesity-focused physicians, and the lifestyle implications for patients using these medications. As we explore this topic further in our series, we aim to uncover what these anti-obesity medications are all about, where they are heading in the future, and what challenges must be addressed along the way.
